This segment is brought to you by LCFAmerica. A new treatment option, SubQ, is helping some lung cancer patients spend less ...
The entrepreneur died of lung cancer at age 56 despite never smoking. Her family is working to make sure "it doesn’t happen ...
About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in ...
PrognomiQ, a healthcare company focused on harnessing the power of proteomics and multi-omics data to transform the detection and early treatment selection and monitoring of cancer, today announced ...
At 43, Shira Boehler was everything the modern health narrative celebrates: disciplined, active, a 6-mile runner, and ...
A new study shows that a simple measurement from routine chest X-rays can help predict survival among patients with lung ...
Around 80,000 lung cancer patients are diagnosed in India each year, the majority at advanced stages of the disease.
In this study, researchers sought to determine if heavy cannabis use is associated with an increased risk of cancer of the lung and bronchus.
New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients?
The Print on MSN
No hours-long drip, it’s a 7-min shot: Roche brings world’s 1st under-the-skin lung cancer drug to India
Roche was granted a Phase 3 clinical trial waiver by CDSCO last year for the Indian launch of Tecentriq SC. The Swiss pharma ...
In part 2 of her interview with The American Journal of Managed Care®, Deborah Doroshow, MD, PhD, assistant professor of ...
Roche brings subcutaneous Atezolizumab to India, shot costs Rs 3.7 lakh per dose with most patients needing around six doses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results